||||||
Diazoxide-resistant focal hyperinsulinism due to sulfonylurea receptor 1 deficiency (disorder)
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency
Hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form
Diazoxide-resistant focal hyperinsulinism due to sulfonylurea receptor 1 deficiency
A rare congenital isolated hyperinsulinism disorder with characteristics of diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to SUR1 deficiency. Hypoglycemia may lead to variable clinical manifestations, ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth, mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus, further leading to poor neurological outcome. Caused by homozygous, compound heterozygous, or heterozygous mutation in the ABCC8 gene on chromosome 11p15.
diazoxideresistent focaal hyperinsulinisme door deficiƫntie van sulfonylureumreceptor 1
diazoxideresistente focale hyperinsulinemie door SUR1-deficiƫntie
Id783740007
StatusPrimitive
DHD Diagnosis thesaurus reference set
ICD-10 complex map reference set
TargetE16.1
RuleTRUE
AdviceALWAYS E16.1 | POSSIBLE REQUIREMENT FOR ADDITIONAL CODE TO FULLY DESCRIBE DISEASE OR CONDITION
CorrelationSNOMED CT source code to target map code correlation not specified